Neurogenic cough is a chronic cough driven by dysfunction in the nerves that control the cough reflex, rather than by an ongoing infection, asthma, or acid reflux. It is thought to result from sensory neuropathy, most commonly without a clear identifiable cause.1PubMed. Neurogenic cough People with the condition often describe a persistent throat tickle or urge to cough that fires in response to triggers as mild as cold air, talking, or perfume. Because standard workups for chronic cough come back normal, many patients spend months or years cycling through treatments for conditions they do not have before the nerve-based origin is recognized.
How Nerve Dysfunction Drives the Cough
A normal cough starts when sensory nerve endings in the airway detect something harmful, like smoke or mucus, and send a signal through the vagus nerve to the brainstem. The brainstem processes that signal and triggers the explosive muscle contractions we experience as a cough. In neurogenic cough, this circuit becomes oversensitive at one or more points along the chain.
At the peripheral level, the sensory nerve endings themselves can become hyperexcitable. Inflammation or injury leaves them firing too easily, sending “cough now” signals in response to stimuli that would not normally provoke a reaction. This hypersensitivity can coexist with other conditions like asthma or reflux, but it often persists even after those conditions are well controlled.2PubMed. Chronic Cough Hypersensitivity as a Neuropathic Disorder: Implications for Management and New Treatments
At the central level, the brain itself can amplify cough signals. Imaging research has found that people with chronic cough hypersensitivity show elevated activity in specific brainstem regions, including the periaqueductal gray, when exposed to cough-provoking stimuli. These same patients also showed signs of reduced ability to suppress the urge to cough, suggesting a two-part problem: the brain both turns up the volume on incoming cough signals and loses some of its normal capacity to override them.3PubMed. Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control
Researchers have borrowed language from the study of chronic pain to describe what happens. “Hypertussia” refers to coughing excessively in response to something that would normally cause only a mild cough, while “allotussia” describes coughing triggered by stimuli that should not provoke any cough at all, like changes in temperature or talking on the phone.4Neuroscience Letters. Mini-review: Hypertussivity and allotussivity in chronic cough endotypes The parallel to chronic pain is more than a metaphor. Just as nerve damage can make a light touch feel excruciating, nerve dysfunction in the airway can make ordinary sensations trigger violent coughing fits.
What Causes the Nerve Damage
The single most commonly identified trigger is a viral upper respiratory infection. A bad cold or flu resolves, but the cough lingers for weeks, then months. A study of patients with postviral vagal neuropathy found that the initial illness involved cough in about nine out of ten cases, along with nasal congestion and runny nose. The group was predominantly female, with a mean age around 48.5PubMed. Postviral vagal neuropathy The virus itself clears, but the inflammation it caused in or around the vagus nerve leaves lasting damage to the sensory fibers.
COVID-19 added a large cohort to this category. Electromyography studies of the laryngeal muscles in patients with persistent post-COVID cough have found patterns consistent with vagus nerve neuropathy, supporting the idea that SARS-CoV-2 can injure the nerve in ways that perpetuate coughing long after the acute infection resolves.6PubMed Central. Chronic cough in post-COVID syndrome: Laryngeal electromyography findings in vagus nerve neuropathy
In many cases, though, no triggering event can be identified. These idiopathic cases are actually the most common category.1PubMed. Neurogenic cough The nerve dysfunction develops without a clear viral illness, surgery, or trauma to point to. This makes it harder to diagnose and sometimes harder for patients to accept, because the absence of a definitive cause can feel like a non-answer.
What It Feels Like
The hallmark complaint is a persistent tickle, itch, or irritation in the throat that will not go away. Patients typically describe the sensation as being located in the larynx or upper airway rather than deep in the chest. Coughing provides little or no relief from the tickle, which is one way it differs from a productive cough where clearing mucus actually helps.
The cough tends to be dry and can come in paroxysms, sudden bouts of uncontrollable coughing that may last several minutes. Triggers are strikingly mundane. People report coughing from laughing, singing, talking on the phone, eating certain textures of food, breathing cold or dry air, or encountering mild fragrances. Patients with chronic cough describe sensory symptoms pointing to upper airway and laryngeal neural dysfunction, with cough triggered by low-level physical and chemical stimuli that support the concept of cough reflex hypersensitivity.7PubMed Central. Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome
Other symptoms commonly travel with the cough. Many patients also experience excessive throat clearing, voice changes like hoarseness or vocal fatigue, and a globus sensation, the feeling that something is stuck in the throat.5PubMed. Postviral vagal neuropathy These overlapping complaints make sense when you consider that the same vagal nerve fibers serving the cough reflex also supply sensation and motor control to the larynx. Damage to the nerve can affect all of these functions at once.
How It Gets Diagnosed
Neurogenic cough is a diagnosis of exclusion. There is no single blood test or scan that confirms it. Instead, clinicians work through the more common causes of chronic cough first: asthma, gastroesophageal reflux, postnasal drip from allergies or sinus disease, and medication side effects. When the workup for these comes back negative or when treatment for them fails to resolve the cough, neurogenic cough moves up the list of possibilities.
Many patients have already been through extensive testing and multiple failed treatments before they reach a specialist who considers a neurogenic origin. A study describing a cohort of patients with sensory neuropathic cough noted that each had been referred to an academic laryngology practice only after extensive prior negative workup and failure to respond to various treatments.8PubMed. Sensory neuropathic cough: a common and treatable cause of chronic cough That pattern of delayed recognition is one of the most frustrating aspects of the condition for patients.
Laryngoscopy, a visual examination of the vocal folds, can sometimes offer clues. Identifying motor paresis, which is slight weakness or impaired movement of one or both vocal folds, may suggest that a sensory neuropathy is also present, since the same nerve serves both functions.1PubMed. Neurogenic cough Laryngeal electromyography can provide more direct evidence of nerve injury by measuring the electrical activity of the laryngeal muscles. These tools are not always definitive on their own, but they can strengthen the clinical picture, especially when combined with a history that fits the pattern: a persistent dry cough following a viral illness, a throat tickle, triggers from benign stimuli, and failure of conventional treatments.
Medication Treatment
Because neurogenic cough behaves like a nerve-pain disorder, the medications that work best are the same ones used for conditions like postherpetic neuralgia and diabetic neuropathy. Low-dose neuromodulators, drugs that calm overexcited nerve signaling, form the backbone of treatment.
A retrospective study of 32 patients treated with these medications found that roughly 94% responded to at least one drug. Patients reported symptom relief during about 78% of amitriptyline trials, 73% of desipramine trials, and 83% of gabapentin trials. At the final doses used, symptom reduction averaged around 77% with amitriptyline, 73% with desipramine, and 69% with gabapentin.9PeerJ. The use of neuralgia medications to treat sensory neuropathic cough: our experience in a retrospective cohort of thirty-two patients These are encouraging numbers, though they come from a single-center retrospective cohort rather than a large randomized trial, so the real-world response rate could be somewhat lower.
The doses used tend to be lower than what is prescribed for depression. Amitriptyline for neurogenic cough, for example, is often started at 10 mg at bedtime and titrated up gradually. Side effects like drowsiness, dry mouth, and constipation are possible, and some patients cannot tolerate these medications long term. When one drug does not work or causes too many side effects, switching to a different neuromodulator in the same family or a different class is common practice.
Newer Drug Targets
The most talked-about emerging treatment involves blocking a receptor called P2X3, which sits on the sensory nerve endings in the airway. When irritants hit these endings, they release a molecule called ATP, which activates the P2X3 receptor and triggers the cough signal. The idea behind P2X3 antagonists is to intercept that signal before it reaches the brain.
Gefapixant is the furthest along in this class and has been evaluated in late-phase clinical trials for refractory or unexplained chronic cough.10The Lancet Respiratory Medicine. Gefapixant, a P3X3 receptor antagonist, versus placebo for the treatment of refractory or unexplained chronic cough (COUGH-1) A meta-analysis pooling data from 11 randomized controlled trials of P2X3 antagonists found a meaningful reduction in 24-hour cough frequency and improvement in cough-related quality of life compared to placebo.11PubMed. Safety and efficacy of P2X3 receptor antagonist for the treatment of refractory or unexplained chronic cough: A systematic review and meta-analysis of 11 randomized controlled trials The main drawback so far is taste disturbance: because P2X3 receptors are also found on taste nerves, many trial participants experienced a reduced or altered sense of taste, sometimes severely enough to discontinue the drug. This side effect has been a major focus of newer molecules in the pipeline that aim to be more selective for the airway receptors.
Speech Therapy and Behavioral Approaches
Medication is not the only option. Speech-language pathology has emerged as an effective non-drug intervention, often used alongside medication. The approach teaches patients specific cough suppression techniques: sipping water when the urge hits, controlled breathing exercises, and substituting the cough with a throat clear or swallow. A systematic review found that speech therapy programs consistently improved cough and cough-related quality of life measures. The programs also include education about how the cough cycle is self-perpetuating, since frequent coughing itself irritates the airway and reinforces the nerve hypersensitivity.12PubMed Central. Curbing the Cough: Multimodal Treatments for Neurogenic Cough: A Systematic Review and Meta-Analysis
This behavioral component matters because the cough can become partly habitual over time. Even after the underlying nerve irritability has been addressed with medication, the brain may have “learned” the cough pattern. Retraining the cough reflex through conscious suppression techniques can break that cycle. In practice, many clinicians recommend both medication and speech therapy together, treating the nerve problem pharmacologically while simultaneously retraining the behavioral response.
Botulinum Toxin Injections
For patients who do not respond adequately to medication and behavioral therapy, botulinum toxin, commonly known as Botox, is another option. Injections are placed in the supraglottic region of the larynx, targeting the sensory territory of the superior laryngeal nerve. A study evaluating this approach found that it provided clinically meaningful reductions in throat irritation without compromising voice function.13PubMed. Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction The idea is to dampen the hyperactive sensory signaling at the source. The effects are temporary, typically lasting a few months, so repeat injections may be needed. This is generally reserved for more severe or refractory cases rather than used as a first-line treatment.
Overlapping Laryngeal Conditions
Neurogenic cough rarely exists in isolation. The same nerve dysfunction that drives the cough can produce a constellation of other laryngeal problems. Paradoxical vocal fold movement, where the vocal folds close inappropriately during breathing and produce a sense of throat tightness or stridor, is increasingly recognized as part of the chronic cough syndrome.14BioMed Central. Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement Dysphonia, or voice problems, is another frequent companion. Patients may notice their voice tiring easily, sounding breathy or strained, or cutting out unpredictably.
Recognizing these overlapping symptoms matters because they all point to the same underlying nerve issue and may all improve with the same treatment. A patient being managed for “a voice problem” and separately for “a chronic cough” by different clinicians may actually have a single condition that would benefit from a unified approach focused on the neuropathy.
The Problem With the “Psychogenic” Label
Historically, chronic cough without an identifiable cause was sometimes labeled “psychogenic,” implying that the cough was essentially a manifestation of psychological distress rather than a physical nerve disorder. This framing has been challenged significantly over the past couple of decades. The terminology has shifted from “psychogenic cough” toward “somatic cough syndrome,” though even the newer term has been criticized for lacking clear definitions and diagnostic criteria.15Wiley Online Library. From Psychogenic Cough to Somatic Cough Syndrome
The problem with the psychogenic label was not just that it was stigmatizing, though it was. It actively misdirected treatment. Patients told their cough was psychological were offered counseling or anxiolytics instead of neuromodulators, missing the opportunity for treatments that have reasonable evidence behind them. Psychological comorbidities like anxiety and depression do exist in many chronic cough patients, but this is likely a consequence of living with a debilitating, socially isolating symptom rather than its root cause. The growing understanding of cough as a neuropathic phenomenon has helped move clinical thinking away from this outdated framing, though some patients still encounter it.
Neurogenic Cough in Children
Neurogenic cough is considered rare in the pediatric population, but it does occur. One published case involved a 12-year-old girl with well-controlled asthma who developed a persistent cough after a viral infection. Standard asthma treatments, including inhaled corticosteroids, bronchodilators, leukotriene inhibitors, and systemic steroids, all failed to resolve it. She was eventually diagnosed with sensory neuropathic cough by a neurologist eight weeks after the cough began and started on amitriptyline, which resolved her symptoms.16Annals of Allergy, Asthma & Immunology. Sensory neuropathic cough in a child: A case report
The challenge in children is that chronic cough is extremely common in pediatric populations for all sorts of routine reasons: lingering postnasal drip, reactive airway disease, recurrent viral infections. Neurogenic cough sits far down the list of probable causes, so it tends to be diagnosed even later than in adults. The postviral pattern, a cough that begins with a cold but persists long after other symptoms resolve and does not respond to standard respiratory treatments, should prompt consideration of a neuropathic cause regardless of the patient’s age. The same neuromodulator medications used in adults can be effective in children, typically at lower doses.
Living With the Condition
Chronic cough of any cause takes a toll that is easy to underestimate if you have not experienced it. People with persistent cough report social embarrassment, disrupted sleep, urinary incontinence triggered by coughing bouts, headaches, and significant anxiety about coughing in public or professional settings. The cough can make it difficult to hold a conversation, attend meetings, eat in restaurants, or enjoy entertainment. These quality-of-life effects are compounded by the diagnostic odyssey many patients endure, bouncing between pulmonologists, allergists, and gastroenterologists before anyone considers a neurogenic origin.
One thing worth knowing if you are in this situation: improvement is realistic. The neuromodulator response rates in available studies are high, and the addition of speech therapy and, if needed, injections provides additional treatment layers. Full resolution is not guaranteed, and some people require long-term medication management, but significant reduction in cough frequency and severity is a reasonable expectation for most patients who receive targeted treatment. Finding a clinician who is familiar with the concept of neurogenic cough, often a laryngologist or a cough specialist, tends to be the hardest step and the most important one.